Dr. Kristie A. Bobolis, MD

Dr. Bobolis practices at Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health.

Dr. Bobolis' NPI, 1932168598, was assigned on March 22, 2006. Dr. Bobolis graduated from UC Irvine School of Medicine in 1985. Dr. Bobolis holds California license 00G582580.

Dr. Bobolis' primary practice is Sutter Medical Center, Sacramento, at 2825 Capitol Avenue, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 454-2222.

Dr. Bobolis' primary practice is Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health. Dr. Bobolis is also affiliated with Sutter Roseville Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Bobolis to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bobolis practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bobolis' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bobolis is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bobolis' licenses on file in 2 states: California and North Carolina.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and purpura and thrombocytopenia among the conditions Dr. Bobolis treats.

CMS data shows 949 Medicare services from Dr. Bobolis across 8 procedure codes in 2024, for 403 Medicare patients. Medicare paid $93,136 for them.

CMS counts 403 Medicare patients who saw Dr. Bobolis in 2024. The largest group is 75 to 84, with 169 patients. 75% of them have cancer, and 70% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bobolis' median patient age at 71, with 89% women.

In 2024, Dr. Bobolis wrote 1,348 Medicare Part D claims for 266 patients. 84% of them were for generic drugs. CMS names the drug for 1,052 of them, across 30 drugs with 11 or more claims each, at $1,432,905 in total drug cost. In 2023, CMS named 948 claims across 26 drugs.

Dr. Bobolis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bobolis as offering telehealth.

Dmand AI links 6 papers to Dr. Bobolis, published from 2016 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Genetic Predisposition to Disease, Biomarkers, Tumor and Breast Neoplasms. Dr. Bobolis' most frequent co-authors are Judy Ellen Garber, MD, Antonis Antoniou, MD and Susan M. Domchek, MD.

Dmand AI links Dr. Bobolis to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 30 general payments to Dr. Bobolis from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Hologic Inc paid the most, $547.

Dmand AI lists 2 awards for Dr. Bobolis.

Dr. Bobolis graduated from UC Irvine School of Medicine in 1985.

Dr. Bobolis is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.